JINXIN FERTILITY GROUP LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3 HKD | +9.89% |
|
+5.30% | -11.04% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 3.21B 445M 3.47B | Sales 2025 * | 3.73B 516M 4.04B | Capitalization | 6.96B 963M 7.53B |
|---|---|---|---|---|---|
| Net income 2024 * | 441M 61.04M 477M | Net income 2025 * | 521M 72.11M 564M | EV / Sales 2024 * | 2.53 x |
| Net Debt 2024 * | 1.16B 160M 1.25B | Net Debt 2025 * | 548M 75.79M 592M | EV / Sales 2025 * | 2.01 x |
| P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
12.8
x | Employees | 3,273 |
| Yield 2024 * |
3.6% | Yield 2025 * |
3.15% | Free-Float | 76.82% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +9.16% | ||
| 1 week | +5.30% | ||
| Current month | +12.03% | ||
| 1 month | +16.86% | ||
| 3 months | +36.70% | ||
| 6 months | -25.69% | ||
| Current year | -11.04% |
1 week
2.71
3.01
1 month
2.243.01
Current year
2.053.40
1 year
2.055.00
3 years
2.0523.50
5 years
2.0524.55
10 years
2.0524.55
| Managers | Title | Age | Since |
|---|---|---|---|
Yang Dong
CEO | Chief Executive Officer | 37 | 18-05-02 |
Rong Lyu
CEO | Chief Executive Officer | 43 | 21-12-02 |
Yong Zhong
CHM | Chairman | 52 | 18-09-11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Min Fang
BRD | Director/Board Member | 45 | 18-12-24 |
John Wilcox
BRD | Director/Board Member | 61 | 18-12-24 |
Yi Jiang Zhuang
BRD | Director/Board Member | 60 | 19-06-02 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.17% | 0 M€ | +2.32% | - | |
| 0.14% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 3 | +9.89% | 21 675 000 |
| 24-05-08 | 2.73 | -1.80% | 11,240,500 |
| 24-05-07 | 2.78 | -1.42% | 13,842,150 |
| 24-05-06 | 2.82 | -0.70% | 26,417,500 |
| 24-05-03 | 2.84 | +0.35% | 7,747,678 |
Delayed Quote Hong Kong S.E., May 08, 2024 at 10:40 pm EDT
More quotes
Jinxin Fertility Group Limited is a China-based company principally engaged in the provision of assisted reproductive services (ARS). The Company operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The Company mainly operates its business in China and the Unites.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
2.524
CNY
Average target price
4.184
CNY
Spread / Average Target
+65.80%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.04% | 980M | |
| +14.31% | 82.36B | |
| -30.46% | 69.97B | |
| +11.55% | 29.41B | |
| +1.46% | 17.08B | |
| -11.30% | 16.99B | |
| -1.26% | 15.21B | |
| +2.64% | 13.25B | |
| +62.55% | 12.12B | |
| +29.68% | 12.08B |
- Stock Market
- Equities
- 1951 Stock